Organisation paid for research Program year 2025 Source: CMS Open Payments

Associated Urological Specialists

Neither a doctor nor a teaching hospital

Research payments

$253,814

35 payments

Through program year 2025, Associated Urological Specialists is reported as receiving $253,814 in research payments, across 35 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$44,120	7
2024	Research	$161,775	17
2023	Research	$47,919	11

Breakdown

Who paid Research payments · program years 2023–2025

Sumitomo Pharma America, Inc. $116,463 21 payments
Dendreon Pharmaceuticals LLC $66,720 10 payments
Janssen Research & Development, LLC $66,631 2 payments
Cytyc Surgical Products, LLC $4,000 2 payments

Studies the money was for Research payments · program years 2023–2025

Relugolix Versus Leuprolide in Patients With Prostate Cancer: A Randomized, Open-Label Study to Assess Major Adverse Cardiovascular Events (Replace-Cv) $72,544 12 payments
A Phase 3, Open-label, Randomized, Prospective Study of Apalutamide Monotherapy Versus Apalutamide Plus Androgen Deprivation Therapy (ADT) in Participants Newly Diagnosed with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) $66,631 2 payments
Relugolix Versus Leuprolide in Patients With Prostate Cancer: A Randomized, Open-Label Study to Assess Major Adverse Cardiovascular Events (Replace-Cv) $43,919 9 payments
ProvONE $38,000 4 payments
ProvONE Study $28,720 6 payments
CSP-00257(BETTER: Control OAB) $4,000 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.